|1.||Torreele, Els: 5 articles (06/2014 - 01/2010)|
|2.||Duchêne, Michael: 5 articles (04/2013 - 08/2007)|
|3.||Leitsch, David: 5 articles (04/2013 - 08/2007)|
|4.||Bray, Michael A: 3 articles (06/2014 - 01/2010)|
|5.||Cerecetto, Hugo: 3 articles (02/2013 - 01/2011)|
|6.||Giglio, Javier: 3 articles (02/2013 - 01/2011)|
|7.||Rey, Ana: 3 articles (02/2013 - 01/2011)|
|8.||Fernández, Soledad: 3 articles (02/2013 - 01/2011)|
|9.||Bourdin Trunz, Bernadette: 3 articles (09/2012 - 01/2010)|
|10.||Kolarich, Daniel: 3 articles (05/2010 - 08/2007)|
01/01/2013 - "[Efficacy of combined 5-nitroimidazole and probiotic therapy of bacterial vaginosis: randomized open trial]."
01/01/2013 - "The application of Gynophilus after conventional 5-nitroimidazole treatment for bacterial vaginosis increased the clinical and microbiological efficacy of the therapy by 25% - 30%. "
08/12/2008 - "[Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis]."
08/12/2008 - "To evaluate the efficacy and adverse effects of 5-nitroimidazole derivatives in treatment of bacterial vaginosis (BV). "
04/01/1996 - "In summary, available evidence suggests that secnidazole is as efficacious as other 5-nitroimidazole drugs in the treatment of protozoal infections and bacterial vaginosis. "
01/01/2010 - "Here it is shown that fexinidazole, a 2-substituted 5-nitroimidazole rediscovered by the Drugs for Neglected Diseases initiative (DNDi) after extensive compound mining efforts of more than 700 new and existing nitroheterocycles, could be a short-course, safe and effective oral treatment curing both acute and chronic HAT and that could be implemented at the primary health care level. "
09/01/2012 - "Fexinidazole, a 2-substituted 5-nitroimidazole rediscovered by the Drugs for Neglected Diseases initiative (DNDi) after extensive compound mining of public and pharmaceutical company databases, has the potential to become a short-course, safe and effective oral treatment, curing both acute and chronic HAT. "
01/01/2012 - "Fexinidazole, a 2-subsituted 5-nitroimidazole drug candidate rediscovered following extensive compound mining by the Drugs for Neglected Diseases initiative and currently in Phase I clinical study for the treatment of human African trypanosomiasis, was evaluated in experimental models of acute and chronic CD caused by different strains of Trypanosoma cruzi. "
06/01/2012 - "Actually, the infection treatment is based on 5-nitroimidazole drugs. "
01/01/2009 - "vaginalis infections are treated with a 5-nitroimidazole derivate. "
10/01/1993 - "It was suggested that H2O2 produced in the inflammatory process during trichomonal infection could enhance the therapeutic effect of 5-nitroimidazole drugs."
08/01/2007 - "Metronidazole, a 5-nitroimidazole drug, has been the gold standard for several decades in the treatment of infections with microaerophilic protist parasites, including Entamoeba histolytica. "
08/01/2014 - "Due to high frequency of the infection during pregnancy and the development of metronidazole-resistant isolates, therapeutic alternatives to 5-nitroimidazole are being searched. "
09/01/2014 - "The first line therapy for amebiasis are 5-nitroimidazole drugs, currently available in the Czech Republic. "
10/01/2014 - "Morinidazole, a 5-nitroimidazole antimicrobial drug, has been approved for the treatment of amoebiasis, trichomoniasis, and anaerobic bacterial infections in China. "
06/15/2014 - "Morinidazole is a novel 5-nitroimidazole derivative used for the treatment of amoebiasis, trichomoniasis, and anaerobic bacterial infections. "
01/01/2013 - "Tinidazole is a 5-nitroimidazole approved in the USA for the treatment of indications including amoebiasis and giardiasis. "
10/01/1982 - "Comparative efficacy of metronidazole and another 5-nitroimidazole, CG-10213-Go, in caecal amoebiasis in albino mice (Mus musculus)."
09/01/2013 - "Metronidazole and tinidazole are effective treatments for most patients with trichomoniasis but not for individuals who are infected with very resistant strains of Trichomonas vaginalis or persons with hypersensitivity to the 5-nitroimidazole drugs. "
09/01/2013 - "However, disulfiram and nithiamide may be useful to treat individuals with hypersensitivity to 5-nitroimidazole drugs and albendazole and coenzyme B12 may be helpful in combination with metronidazole or tinidazole for treatment of persons with highly resistant T vaginalis infections."
|1.||Drug Therapy (Chemotherapy)
|2.||Transplantation (Transplant Recipients)
|3.||Combination Drug Therapy (Combination Chemotherapy)